Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/8/2026

Management of Non‑Burn Blister Formation

Diagnostic Evaluation

  • Assess the distribution pattern of blisters to distinguish localized friction blisters from disseminated autoimmune bullous diseases such as pemphigus vulgaris or bullous pemphigoid【1】【2】.
  • A positive Nikolsky sign (skin separates with lateral pressure) indicates pemphigus vulgaris or other severe bullous disorders【2】【3】.
  • Mucosal involvement (oral, genital, ocular lesions) points toward pemphigus vulgaris rather than friction or contact dermatitis【2】【3】.
  • Presence of systemic signs (fever, hemodynamic instability, extensive skin involvement) warrants intensive supportive care【2】【3】.
  • Onset and progression help differentiate acute friction‑induced blisters from sub‑acute autoimmune bullous disease【1】【2】.
  • Review medication history for possible drug‑induced bullous reactions【2】.
  • A family history may suggest inherited genetic bullous disorders【2】.

Immediate Care of Intact Blisters

  • Gentle antimicrobial cleansing of intact blisters without rupturing them before any intervention reduces infection risk【2】【3】【4】【5】.
  • Pierce the blister base with a sterile needle (bevel up) at a site where gravity assists drainage; this technique minimizes pain and preserves the roof as a biological dressing【2】【3】【4】【5】.
  • Apply gentle pressure with sterile gauze to facilitate fluid evacuation【2】【3】【4】【5】.
  • Do not deroof the blister; the intact roof provides optimal biological coverage and promotes healing【2】【3】【4】【5】.
  • After drainage, re‑cleanse with antimicrobial solution before dressing application【2】【3】【4】【5】.
  • Use a non‑adherent dressing as needed to protect the site【2】【3】【4】【5】.
  • For large blisters, employ a larger‑gauge needle and multiple puncture sites to achieve adequate drainage【2】【3】【4】【5】.
  • Piercing causes less discomfort than aspiration, supporting its use as the preferred method【2】【3】【4】【5】.

Management of Ruptured or Infected Blisters

  • When infection is suspected (erythema, warmth, purulent drainage, extending cellulitis), obtain bacterial and viral swabs before treatment【2】【3】【4】【5】.
  • Apply topical antimicrobials for a short course only to limit resistance development【2】【3】【4】【5】.
  • Initiate systemic antibiotics promptly, guided by local antibiogram, for any clinical signs of infection【2】【3】【4】【5】.

Supportive Care

  • Bland emollient (50 % white soft paraffin / 50 % liquid paraffin) should be applied to support barrier function and promote re‑epithelialization【2】【3】【4】【5】.
  • Perform daily antimicrobial washing to decrease skin colonization【2】【3】【4】【5】.
  • Use aseptic dressing changes for extensive erosions and provide barrier nursing to protect vulnerable skin【2】【3】【4】【5】.
  • Analgesia should be offered before blister‑care procedures because patients commonly report a burning sensation【2】【3】【4】【5】; both acute and maintenance analgesics with the option for additional dosing during dressing changes are recommended【2】【3】【4】【5】.
  • Pain‑team consultation is advised for severe or refractory pain【2】【3】【4】【5】.
  • Infection and sepsis are major mortality drivers in bullous diseases; vigilant surveillance is essential【2】【3】【4】【5】.
  • Maintain a daily blister chart documenting number and location of new lesions【2】【3】【4】【5】.
  • Monitor fluid balance, hemodynamic stability, thermoregulation, and nutritional intake regularly【2】【3】【4】【5】.
  • Prevent further trauma by careful skin handling by specialized nursing staff【2】【3】【4】【5】.

Pharmacologic Treatment of Bullous Pemphigoid (Mild Disease)

  • Clobetasol propionate 20 g daily applied to the entire body (10 g if weight < 45 kg) is the first‑line topical regimen【1】.
  • Reduce the clobetasol dose after 15 days once disease control is achieved【1】.
  • Taper gradually with the goal of discontinuation within 4–12 months【1】.
  • If control is inadequate within 1–3 weeks, increase to 40 g daily【1】.
  • An alternative systemic option is prednisone 0.5 mg/kg/day for mild disease【1】.
  • Taper prednisone to a maintenance dose of 0.1 mg/kg/day over 4–6 months【1】.
  • Total treatment duration should be 4–12 months【1】.
  • Prednisone doses < 0.5 mg/kg/day are ineffective and not validated for bullous pemphigoid【1】.

Management of Pemphigus Vulgaris

  • Requires specialist dermatology management with systemic immunosuppression; no specific regimen is detailed here【2】【3】【4】【5】.

Common Pitfalls to Avoid

  • Never aspirate blisters—piercing is less painful and preserves the biological dressing【2】【3】【4】【5】.
  • Never deroof intact blisters; the roof provides optimal coverage and promotes healing【2】【3】【4】【5】.
  • Avoid prolonged topical antimicrobial use; limit to short courses to prevent resistance【2】【3】【4】【5】.
  • Do not delay systemic antibiotics when infection signs are present, as delays increase scarring risk and mortality【2】【3】【4】【5】.

Guideline for Management of Edema Blisters

Primary Management

  • Pierce edema blisters at the base with a sterile needle (bevel up) to drain fluid while preserving the blister roof as a biological dressing, then apply a bland emollient and a non‑adherent dressing; rapid resolution follows correction of the underlying fluid overload. 6

Care of Intact Blisters

  • Clean the blister gently with an antimicrobial solution without rupturing it to lower infection risk. 6, 7, 8
  • Pierce the blister base with a sterile needle (bevel up) at a gravity‑favored site; this method causes less discomfort than aspiration. 6, 7
  • Apply gentle pressure with sterile gauze to evacuate fluid and absorb drainage. 6, 7, 8
  • Never deroof an intact blister—the roof provides optimal biological coverage and promotes healing. 6, 7, 8, 9
  • After drainage, re‑cleanse the area with antimicrobial solution. 6, 7, 8
  • Cover with a non‑adherent dressing as needed to protect the site. 6, 7, 8
  • For large blisters, use a larger‑gauge needle and create multiple puncture sites to achieve adequate drainage. 6, 7, 8
  • Offer analgesia before the procedure because patients commonly report burning or pain during blister care. 6, 7, 8

Care of Already‑Ruptured Blisters

  • Remove only loose, fluttering skin; leave any adherent blister roof in place. 9
  • Apply a bland emollient (approximately 50 % white soft paraffin / 50 % liquid paraffin) to support barrier function, reduce trans‑cutaneous water loss, and encourage re‑epithelialization. 6, 7, 8

Infection Prevention and Management

  • Perform daily antimicrobial washing to decrease bacterial colonisation. 6, 7, 8
  • Use aseptic technique for dressing changes and provide barrier nursing for extensive erosions. 6, 7, 8
  • Obtain bacterial and viral swabs if infection is suspected (e.g., erythema, warmth, purulent drainage, extending cellulitis). 6, 7, 8
  • Apply topical antimicrobials for short courses only to limit resistance development. 6, 7, 8
  • Initiate systemic antibiotics promptly when local or systemic signs of infection develop, guided by the local antibiogram; infection increases scarring risk and mortality. 6, 7, 8

Supportive Care Measures

  • Keep a daily blister chart documenting the number and location of new lesions to track disease progress. 6, 7, 8
  • Monitor fluid balance, haemodynamic stability, thermoregulation, and nutritional intake regularly. 6, 8
  • Provide both acute and maintenance analgesia, with additional dosing available for dressing changes; consider pain‑team consultation for severe or refractory pain. 6, 8
  • Handle skin carefully using specialised nursing staff familiar with skin‑failure management. 6, 8

Treatment of Underlying Edema

  • Use diuretic therapy for patients with cardiac or renal failure to address the root cause of fluid overload. 10

Critical Pitfalls to Avoid

  • Do not aspirate blisters; piercing is less painful and better preserves the biological dressing. 6, 7
  • Do not deroof intact blisters; the roof provides optimal coverage and promotes healing. 6, 7, 8, 9
  • Do not use prolonged topical antimicrobials; limit to short courses to prevent resistance. 6, 7, 8
  • Do not delay systemic antibiotics when infection is present; delays increase scarring risk and mortality. 6, 7, 8
  • Do not confuse edema blisters with autoimmune bullous diseases (e.g., pemphigus vulgaris, bullous pemphigoid) or drug reactions (e.g., Stevens‑Johnson syndrome); those conditions require immunosuppression, whereas edema blisters lack mucosal involvement, have a negative Nikolsky sign, and resolve with edema reduction alone. 11, 10, 12

REFERENCES